168 related articles for article (PubMed ID: 18582929)
1. Selective factor Xa inhibition for thromboprophylaxis.
Eikelboom JW; Weitz JI
Lancet; 2008 Jul; 372(9632):6-8. PubMed ID: 18582929
[No Abstract] [Full Text] [Related]
2. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Vink R; Sohne M
N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675668
[No Abstract] [Full Text] [Related]
3. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Derksen RJ; Mulder WM; Mulder JW
N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675667
[No Abstract] [Full Text] [Related]
4. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Alameddine R; Husari A
N Engl J Med; 2013 May; 368(20):1944-5. PubMed ID: 23675666
[No Abstract] [Full Text] [Related]
5. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT; Spiro TE; Spyropoulos AC;
N Engl J Med; 2013 May; 368(20):1945-6. PubMed ID: 23675665
[No Abstract] [Full Text] [Related]
6. Rivaroxaban for thromboprophylaxis.
Schuman EP
N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19005203
[No Abstract] [Full Text] [Related]
7. [Rivaroxaban for thromboprophylaxis inpatients with acute medical illness].
Ruiz Muñoz M
Rev Clin Esp (Barc); 2013; 213(5):257. PubMed ID: 23940851
[No Abstract] [Full Text] [Related]
8. New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Verma AK
ANZ J Surg; 2009 Nov; 79(11):773-4. PubMed ID: 20078521
[No Abstract] [Full Text] [Related]
9. Rivaroxaban for thromboprophylaxis.
ten Cate H; Hamulyak K
N Engl J Med; 2008 Nov; 359(20):2174-5; author reply 2176. PubMed ID: 19009676
[No Abstract] [Full Text] [Related]
10. Rivaroxaban for thromboprophylaxis.
Lotke PA
N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009675
[No Abstract] [Full Text] [Related]
11. New anticoagulants--the path from discovery to clinical practice.
Lohrmann J; Becker RC
N Engl J Med; 2008 Jun; 358(26):2827-9. PubMed ID: 18579818
[No Abstract] [Full Text] [Related]
12. Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery.
Belavic JM
Nurse Pract; 2012 May; 37(5):6-8. PubMed ID: 22543875
[No Abstract] [Full Text] [Related]
13. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
[TBL] [Abstract][Full Text] [Related]
17. Development of oral anticoagulants.
Ma Q
Br J Clin Pharmacol; 2007 Sep; 64(3):263-5. PubMed ID: 17506786
[No Abstract] [Full Text] [Related]
18. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
Yen SH; Lin PC; Kuo FC; Wang JW
Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V;
N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003
[TBL] [Abstract][Full Text] [Related]
20. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
